LG HONORED WITH TOYOTA'S "EXCELLENT VALUE IMPROVEMENT AWARD" FOR THE FIRST TIME

Company's Outstanding Efforts in Delivery and Collaborative Cost Reduction Recognized by the World's Largest Car Manufacturer

SEOUL, South Korea, April 22, 2025 /PRNewswire/ -- LG Electronics (LG), a mobility sector technology leader, has been awarded the 2024 Excellent Value Improvement Award by Toyota Motor North America (TMNA) for the first time. The award was presented at TMNA's Annual Supplier Business Meeting in the U.S. This award recognizes LG's contributions to component quality and technological innovation in Toyota's largest market, North America.

To determine the award winners, TMNA evaluates supplier performance based on key criteria such as technology and development, supplier diversity, value improvement, Value Analysis achievement, quality, launch and value chain promotion. LG was highly commended for its outstanding delivery and proactive support of cost innovation initiatives. The company's commitment to on-time, high-quality supply chain management has ensured seamless operations for Toyota, while its collaborative approach to cost optimization prioritizes continuous improvement over simple price reductions. LG also excelled in Manufacturing Improvement, demonstrating resilience and operational excellence in the challenging post-pandemic landscape.

LG has been a trusted partner of Toyota since supplying Navi-box components for its vehicles in 2011. This partnership expanded in 2019 to include advanced telematics solutions for TMNA. The LG Vehicle Solution Company leverages its expertise in 5G telematics technology to deliver advanced connectivity solutions tailored for the automotive industry. The company provides versatile telematics control units (TCUs) available in both standalone and integrated-antenna configurations. These TCUs feature cutting-edge capabilities, including 5G connectivity, Vehicle-to-Everything (V2X) communication, and robust cybersecurity measures. Such innovations enable automakers to offer seamless connectivity, efficiently supporting the growing demands of connected and autonomous driving. Through close collaboration with global automakers, LG continues to drive innovation and reinforce its leadership position in automotive telematics.

"LG's commitment to collaboration and continuous improvement has been outstanding," said Ryan Grimm, Group Vice President of TMNA R&D Purchasing Supplier Development. "We appreciate LG's proactive approach to meeting our evolving needs and look forward to building on this strong foundation as we move forward together."

"This highly esteemed award validates our efforts in advancing automotive technology and underscores our commitment to collaboration and building customer trust," said Brad Oh, president of LG Vehicle Solution USA. "Our advanced telematics solutions prioritize vehicle connectivity and safety, helping Toyota realize its vision for the future of mobility through cutting-edge technologies and continued partnership."

About LG Electronics Vehicle Solution Company

The LG Vehicle Solution Company (VS) is bringing LG's unique human-centered innovations to the automotive industry. As a trusted and innovative partner, the company provides intelligent solutions including head units, displays, connectivity, ADAS vision systems, and software solutions for software-defined vehicles. Committed to "Driving Better Future Mobility," the company has diversified its portfolio to further strengthen its capabilities. This includes the acquisition of automotive lighting systems provider ZKW Group and vehicle cybersecurity company Cybellum, as well as the establishment of the LG Magna e-Powertrain joint venture. For more information, visit www.LG.com/global/mobility. To stay updated with the latest news, subscribe to the LG mobility newsletter, LG Loop at www.LG.com/global/mobility/newsletter and follow the LG VS Company LinkedIn channel at www.linkedin.com/company/lgvehiclesolution. 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

LG HONORED WITH TOYOTA'S "EXCELLENT VALUE IMPROVEMENT AWARD" FOR THE FIRST TIME

AUCKLAND, New Zealand, May 2, 2025 /PRNewswire/ -- Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence.

There are now over 100 peer-reviewed studies describing the efficacy of the company's proprietary AROA ECM technology.

AROA's most recent publication was a large retrospective analysis of real-world evidence (RWE) from wound care centers in the US, assessing the efficacy of the company's Endoform Natural^TM product in treating venous leg ulcers (VLUs), in comparison to a leading reconstituted collagen dressing.

VLU's are open sores that are hard-to-heal because of impaired blood flow and can be very debilitating and painful.  These types of wounds are difficult for clinicians to treat successfully. For example, only ~40% of VLUs can be healed after 3 months of treatment and there is a relatively high chance that these wounds will recur^[1].

The peer-reviewed study, entitled "Clinical Efficacy of Ovine Forestomach Matrix and Collagen/Oxidized Regenerated Cellulose for the Treatment of Venous Leg Ulcers: A Retrospective Comparative Real-World Evidence Study" was published in the open access journal 'International Wound Journal in April 2025.

The study compared 470 VLU's that had been treated with Endoform Natural to 360 VLU's that had been treated with a reconstituted collagen product. The study used existing data from 223 wound care centers with minimal inclusion or exclusion criteria so that 'real-world' use of both products could be compared.

"There is a growing awareness of RWE studies to validate clinical performance" says Chief Scientific Officer, Dr. Barnaby May. "These types of studies enable much larger patient numbers to be compared versus traditional randomized controlled trials. Given that RWE studies use data from 'real-world' use of a treatment, the results can be more meaningful, especially in wound care where there is a high degree of variability in how wounds are cared for and patient factors."

The study found that VLUs treated with Endoform Natural healed up to ~ 8 weeks faster versus the comparator group, and the chances of the wound healing were significantly improved when Endoform Natural was used as part of treatment.

The striking difference in the healing outcomes demonstrate the potential for considerable cost reductions and improvements in patient quality of life, due to the significant improvements seen when VLUs were treated using Endoform Natural.

Dr. Gregory Bohn MD was part of the research team. "I was first introduced to Endoform in 2012 and started using the product to treat my own patients with VLUs. This new data validates what I have seen in my own practice managing VLUs with Endoform."

This is the second large retrospective RWE comparing Endoform Natural to a leading reconstituted collagen dressing. A previous study included the analysis of over 2,200 diabetic foot ulcers (DFUs) and also demonstrated significantly faster healing of DFUs using Endoform Natural^[2].

The study is available online here.

[1] Kolluri R, Lugli M, Villalba L, Varcoe R, Maleti O, Gallardo F, et al. An estimate of the economic burden of venous leg ulcers associated with deep venous disease. Vasc Med. 2022;27(1):63-72.

[2] Bosque BA, Frampton C, Chaffin AE, Bohn GA, Woo K, DeLeonardis C, Lepow BD, Melin MM, Madu T, Dowling SG, May BCH. Retrospective real-world comparative effectiveness of ovine forestomach matrix and collagen/ORC in the treatment of diabetic foot ulcers. Int Wound J. 2022 May;19(4):741-753.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

AROA hits evidence milestone with real-world study validating the efficacy of Endoform in treating challenging venous leg ulcers.